A Clinical Triad with Fatal Implications: Recrudescent Diffuse Large B-cell Non-Hodgkin Lymphoma Presenting in the Leukemic Phase with an Elevated Serum Lactic Acid Level and Dysregulation of the TP53 Tumor Suppressor Gene

Overview

cited authors

Hwang, Catherine S.; Hwang, Dick G.; Aboulafia, David M.

authors

Hwang, Catherine S., MD

Publication Date

February 1, 2021

webpage

Web of Science

published in

CLINICAL MEDICINE INSIGHTS-BLOOD DISORDERS Journal

Research

keywords

DLBCL
TP53 tumor suppressor gene dysregulation
elevated serum lactic acid
leukemic phase
non-Hodgkin lymphoma

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.